Janssen Pharmaceuticals N.V (JA-733)
| Audit # | JA-733 |
|---|---|
| Region | Europe |
| Standards | API/Excipients |
| Company | Janssen Pharmaceuticals N.V |
| Location | Geel, Belgium |
| Date | 8-9 February 2016 |
| Materials | API:;Etomidate R016659;Haloperidol R001625;Piritramide R003365;Haloperidol decanoate R013672;Bromperidol decanoate R046541;Fluspirilene R006218;Alfentanil Hydrochloride;Sufentanil Citrate;Intraconazole 00024567;Excipient:;Fentanyl Citrate R005240 |
* If you do not have access to auditsPLUS database and would like to join this audit contact Simone Ziss at sziss@rx-360.org
* If you do not have access to auditsPLUS database and would like to license this audit contact Jaye Greene at jgreene@rx-360.org